Mhr Fund Management LLC Iovance Biotherapeutics, Inc. Transaction History
Mhr Fund Management LLC
- $568 Million
- Q2 2025
A detailed history of Mhr Fund Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mhr Fund Management LLC holds 28,967,103 shares of IOVA stock, worth $64.6 Million. This represents 8.78% of its overall portfolio holdings.
Number of Shares
28,967,103
Previous 24,417,103
18.63%
Holding current value
$64.6 Million
Previous $81.3 Million
38.72%
% of portfolio
8.78%
Previous 12.15%
Shares
5 transactions
Others Institutions Holding IOVA
# of Institutions
290Shares Held
233MCall Options Held
1.24MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA25.1MShares$55.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$47.3 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$26.4 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.33MShares$20.8 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $352M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...